Drug recall · January 24, 2024
Ibuprofen and Famotidine Tablets 800mg/26.6mg recall
Why: Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ibuprofen and Famotidine Tablets 800mg/26.6mg, Rx Only, 90 Tablets per Bottle, manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-626-90
- Lots / codes
23140190, Exp. Date 12/31/2024
- Quantity
- 3,288 bottles
- Company
- Ascend Laboratories, LLC, Parsippany, NJ
- Distribution
- Nationwide
- Initiated
- December 29, 2023 · Voluntary: Firm initiated
- Classified
- January 17, 2024
- Reported
- January 24, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Famotidine / ibuprofen
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.